Organigram Holdings Sunday Midday Brief OGI BAT Strategic Capital and International Medical Cannabis Expansion Frame FY2026 Revenue Thesis
TL;DR: Organigram Holdings has leveraged its British American Tobacco strategic partnership to build research capabilities and international distribution channels that distinguish the Canadian LP from peers competing primarily on domestic market share. OGI’s NASDAQ listing and substantial BAT investment provide a capital foundation positioning the company to pursue medical cannabis market access in Germany and […]
MSOS ETF Sunday Morning Brief Cannabis Sector Benchmark Advances 2.48 Percent Entering Q2 2026 Earnings Season
TL;DR: The AdvisorShares Pure US Cannabis ETF (MSOS) advanced 2.48% in the holiday-shortened trading week ending July 3, 2026, as the benchmark cannabis sector fund entered Sunday’s market break with net assets of $1.02 billion and a one-year return exceeding 100%. With U.S. multi-state operators preparing to report Q2 2026 results over the next six […]
Cannabis Sector Saturday Evening Close July 4 Holiday Retail Demand Trends and Q2 2026 Earnings Season Week Preview for U.S. MSOs
TL;DR: July 4th ranks among the highest single-day cannabis retail volume events of the calendar year, and this holiday weekend’s consumer demand data will serve as an early Q2 2026 revenue signal for U.S. multi-state operators. With Q2 earnings season scheduled to open in late July and August, institutional investors monitoring leading MSOs will use […]
Curaleaf Holdings Saturday Midday Analysis CURLF Multi-State Scale and European Operations Frame Q2 2026 Revenue Thesis Ahead of August Earnings
TL;DR: Curaleaf Holdings (CSE: CURA / OTC: CURLF), North America’s largest cannabis operator by retail footprint, enters the July 4 holiday weekend with approximately 140 dispensaries across 17 U.S. states and a growing European presence through EMMAC Life Sciences. With Q2 2026 results expected in mid-August, analyst attention is centered on domestic revenue recovery, operating […]
Cannabis Rescheduling Pipeline Update Q3 2026 DEA Administrative Hearing Calendar Advances as 280E Relief Timeline Shapes MSO Balance Sheet Modeling
TL;DR: The DEA’s administrative hearing process on the proposed rescheduling of cannabis from Schedule I to Schedule III has advanced into Q3 2026, with procedural calendar milestones that could produce a final rule determination in the fourth quarter. Resolution of the 280E tax treatment — the most financially consequential downstream effect of rescheduling — has […]
Cannabis Sector Friday Close: Five Catalysts to Monitor the Week of July 7 as Q2 2026 Earnings Season Enters Execution Phase
TL;DR: The cannabis sector closes a productive holiday-shortened trading week with broad-based gains across major multistate operators and Canadian licensed producers, as the MSOS ETF digests pre-holiday positioning ahead of a catalyst-heavy July. Five near-term data points will shape price action when full trading volume resumes July 7. Investors should prioritize Schedule III administrative updates […]
Schwazze Friday Midday Analysis: SHWZ Colorado-New Mexico Platform Carries $175 Million Revenue Base Into Q2 2026 With Filing Delay Overhang
TL;DR: Medicine Man Technologies (OTC: SHWZ), operating as Schwazze, enters the Q2 2026 reporting window carrying a delayed filings overhang that has suppressed institutional interest since the audit committee investigation was disclosed in late 2024. With trailing twelve-month revenue of approximately $175 million and a dominant position in Colorado cannabis retail, the underlying business remains […]
Cannabis Sector Friday Morning Brief MSOS ETF Enters July 4 Holiday Weekend as Q2 2026 Earnings Season Approaches
TL;DR The cannabis equity sector enters the July 4 holiday weekend with the AdvisorShares Pure US Cannabis ETF (MSOS) consolidating near multi-month highs following a productive first half of 2026. Pre-market signals are mixed as institutional participants reduce exposure ahead of a shortened Friday session. The next major catalyst window for the sector is Q2 […]
OrganiGram Holdings Thursday Midday Brief: OGI BAT Partnership Capital and Automated Capacity Drive Q3 FY26 Canadian LP Thesis into Second-Half Inflection
TL;DR: OrganiGram Holdings (NASDAQ: OGI) heads into its Q3 FY2026 reporting period with a structurally improved cost position, a deepening strategic partnership with British American Tobacco that provides both capital access and international distribution optionality, and growing Canadian market share in the premium and value flower segments. The Moncton-based LP’s investment in automation and next-generation […]
Canopy Growth Thursday Morning Brief: CGC Nears Sub-Dollar Level Ahead of August 7 Earnings as Portfolio Rationalization Defines Q4 FY26 Thesis
TL;DR: Canopy Growth (CGC) closed Wednesday at $0.9487, hovering just below the $1.00 threshold, as the Canadian LP approaches its August 7 earnings date with a leaner asset base and a Q4 FY26 revenue consensus of $71.25M. With the BioSteel wind-down complete and legacy acquisition liabilities largely resolved, the August print will test whether portfolio […]